Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Mar;83(6):1817–1821. doi: 10.1073/pnas.83.6.1817

Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders.

O T Mueller, W M Henry, L L Haley, M G Byers, R L Eddy, T B Shows
PMCID: PMC323175  PMID: 3081902

Abstract

The inherited human disorders sialidosis and galactosialidosis are the result of deficiencies of glycoprotein-specific alpha-neuraminidase (acylneuraminyl hydrolase, EC 3.2.1.18; sialidase) activity. Two genes were determined to be necessary for expression of neuraminidase by using human-mouse somatic cell hybrids segregating human chromosomes. A panel of mouse RAG-human hybrid cells demonstrated a single-gene requirement for human neuraminidase and allowed assignment of this gene to the (pter----q23) region of chromosome 10. A second panel of mouse thymidine kinase (TK)-deficient LM/TK- -human hybrid cells demonstrated that human neuraminidase activity required both chromosomes 10 and 20 to be present. Analysis of human neuraminidase expression in interspecific hybrid cells or polykaryocytes formed from fusion of mouse RAG (hypoxanthine/guanine phosphoribosyltransferase deficient) or LM/TK- cell lines with human sialidosis or galactosialidosis fibroblasts indicated that the RAG cell line complemented the galactosialidosis defect, but the LM/TK- cell line did not. This eliminates the requirement for this gene in RAG-human hybrid cells and explains the different chromosome requirements of these two hybrid panels. Fusion of LM/TK- cell hybrids lacking chromosome 10 or 20 (phenotype 10+,20- and 10-,20+) and neuraminidase-deficient fibroblasts confirmed by complementation analysis that the sialidosis disorder results from a mutation on chromosome 10, presumably encoding the neuraminidase structural gene. Galactosialidosis is caused by a mutation in a second gene required for neuraminidase expression located on chromosome 20.

Full text

PDF
1817

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andria G., Del Giudice E., Reuser A. J. Atypical expression of beta-galactosidase deficiency in a child with Hurler-like features but without neurological abnormalities. Clin Genet. 1978 Jul;14(1):16–23. doi: 10.1111/j.1399-0004.1978.tb02055.x. [DOI] [PubMed] [Google Scholar]
  2. Cantz M., Gehler J., Spranger J. Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts. Biochem Biophys Res Commun. 1977 Jan 24;74(2):732–738. doi: 10.1016/0006-291x(77)90363-1. [DOI] [PubMed] [Google Scholar]
  3. Champion M. J., Shows T. B. Correction of human mucolipidosis II enzyme abnormalities in somatic cell hybrids. Nature. 1977 Nov 3;270(5632):64–66. doi: 10.1038/270064a0. [DOI] [PubMed] [Google Scholar]
  4. D'Azzo A., Hoogeveen A., Reuser A. J., Robinson D., Galjaard H. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4535–4539. doi: 10.1073/pnas.79.15.4535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Durand P., Gatti R., Cavalieri S., Borrone C., Tondeur M., Michalski J. C., Strecker G. Sialidosis (mucolipidosis I). Helv Paediatr Acta. 1977 Nov;32(4-5):391–400. [PubMed] [Google Scholar]
  6. Galjaard H., Hoogeveen A., de Wit-Verbeek H. A., Reuser A. J., Ho M. W., Robinson D. Genetic heterogeneity in GM1-gangliosidosis. Nature. 1975 Sep 4;257(5521):60–62. doi: 10.1038/257060a0. [DOI] [PubMed] [Google Scholar]
  7. Goldberg M. F., Cotlier E., Fichenscher L. G., Kenyon K., Enat R., Borowsky S. A. Macular cherry-red spot, corneal clouding, and beta-galactosidase deficiency. Clinical, biochemical, and electron microscopic study of a new autosomal recessive storage disease. Arch Intern Med. 1971 Sep;128(3):387–398. [PubMed] [Google Scholar]
  8. Hoogeveen A. T., Verheijen F. W., d'Azzo A., Galjaard H. Genetic heterogeneity in human neuraminidase deficiency. Nature. 1980 Jun 12;285(5765):500–502. doi: 10.1038/285500a0. [DOI] [PubMed] [Google Scholar]
  9. Hoogeveen A., d'Azzo A., Brossmer R., Galjaard H. Correction of combined beta-galactosidase/neuraminidase deficiency in human fibroblasts. Biochem Biophys Res Commun. 1981 Nov 16;103(1):292–300. doi: 10.1016/0006-291x(81)91692-2. [DOI] [PubMed] [Google Scholar]
  10. Klobutcher L. A., Nichols E. A., Kucherlapati R. S., Ruddle F. H. Assignment of the gene for human adenosine kinase to chromosome 10 using a somatic cell hybrid clone panel. Birth Defects Orig Artic Ser. 1976;12(7):171–174. [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Loonen M. C., Reuser A. J., Visser P., Arts W. F. Combined sialidase (neuraminidase) and beta-galactosidase deficiency. Clinical, morphological and enzymological observations in a patient. Clin Genet. 1984 Aug;26(2):139–149. doi: 10.1111/j.1399-0004.1984.tb00804.x. [DOI] [PubMed] [Google Scholar]
  13. Lowden J. A., O'Brien J. S. Sialidosis: a review of human neuraminidase deficiency. Am J Hum Genet. 1979 Jan;31(1):1–18. [PMC free article] [PubMed] [Google Scholar]
  14. Maire I., Nivelon-Chevallier A. R. Combined deficiency of beta-galactosidase and neuraminidase: three affected siblings in a French family. J Inherit Metab Dis. 1981;4(4):221–223. doi: 10.1007/BF02263656. [DOI] [PubMed] [Google Scholar]
  15. Miyatake T., Yamada T., Suzuki M., Pallmann B., Sandhoff K., Ariga T., Atsumi T. Sialidase deficiency in adult-type neuronal storage disease. FEBS Lett. 1979 Jan 15;97(2):257–259. doi: 10.1016/0014-5793(79)80097-6. [DOI] [PubMed] [Google Scholar]
  16. Mueller O. T., Shows T. B. Human beta-galactosidase and alpha-neuraminidase deficient mucolipidosis: genetic complementation analysis of the neuraminidase deficiency. Hum Genet. 1982;60(2):158–162. doi: 10.1007/BF00569704. [DOI] [PubMed] [Google Scholar]
  17. Mueller O. T., Wenger D. A. Mucolipidosis I: studies of sialidase activity and a prenatal diagnosis. Clin Chim Acta. 1981 Feb 5;109(3):313–324. doi: 10.1016/0009-8981(81)90317-x. [DOI] [PubMed] [Google Scholar]
  18. Norwood T. H., Zeigler C. J., Martin G. M. Dimethyl sulfoxide enhances polyethylene glycol-mediated somatic cell fusion. Somatic Cell Genet. 1976 May;2(3):263–270. doi: 10.1007/BF01538964. [DOI] [PubMed] [Google Scholar]
  19. Oohira T., Nagata N., Akaboshi I., Matsuda I., Naito S. The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: possible linkage between HLA and the neuraminidase deficiency gene. Hum Genet. 1985;70(4):341–343. doi: 10.1007/BF00295374. [DOI] [PubMed] [Google Scholar]
  20. Shows T. B., Brown J. A., Haley L. L., Byers M. G., Eddy R. L., Cooper E. S., Goggin A. P. Assignment of the beta-glucuronidase structural gene to the pter leads to q22 region of chromosome 7 in man. Cytogenet Cell Genet. 1978;21(1-2):99–104. doi: 10.1159/000130882. [DOI] [PubMed] [Google Scholar]
  21. Shows T. B. Proceedings: Synteny of human genes for glutamic oxalacetic transaminase and hexokinase in somatic cell hybrids. Cytogenet Cell Genet. 1974;13(1):143–145. doi: 10.1159/000130258. [DOI] [PubMed] [Google Scholar]
  22. Shows T., Eddy R., Haley L., Byers M., Henry M., Fujita T., Matsui H., Taniguchi T. Interleukin 2 (IL2) is assigned to human chromosome 4. Somat Cell Mol Genet. 1984 May;10(3):315–318. doi: 10.1007/BF01535253. [DOI] [PubMed] [Google Scholar]
  23. Sips H. J., de Wit-Verbeek H. A., de Wit J., Westerveld A., Galjaard H. The chromosomal localization of human beta-galactosidase revisited: a locus for beta-galactosidase on human chromosome 3 and for its protective protein on human chromosome 22. Hum Genet. 1985;69(4):340–344. doi: 10.1007/BF00291653. [DOI] [PubMed] [Google Scholar]
  24. Strisciuglio P., Creek K. E., Sly W. S. Complementation, cross correction, and drug correction studies of combined beta-galactosidase neuraminidase deficiency in human fibroblasts. Pediatr Res. 1984 Feb;18(2):167–171. doi: 10.1203/00006450-198402000-00011. [DOI] [PubMed] [Google Scholar]
  25. Suzuki Y., Sakuraba H., Hayashi K., Suzuki K., Imahori K. Beta-galactosidase-neuraminidase deficiency: restoration of beta-galactosidase activity by protease inhibitors. J Biochem. 1981 Jul;90(1):271–273. doi: 10.1093/oxfordjournals.jbchem.a133462. [DOI] [PubMed] [Google Scholar]
  26. Suzuki Y., Sakuraba H., Potier M., Akagi M., Sakai M., Beppu H. beta-Galactosidase-neuraminidase deficiency in adults: deficiency of a freeze-labile neuraminidase in leukocytes and fibroblasts. Hum Genet. 1981;58(4):387–389. doi: 10.1007/BF00282820. [DOI] [PubMed] [Google Scholar]
  27. Swallow D. M., Hoogeveen A. T., Verheijen F. W., Galjaard H. Complementation analysis of human sialidase deficiency using natural substrates. Ann Hum Genet. 1981 May;45(Pt 2):105–112. doi: 10.1111/j.1469-1809.1981.tb00311.x. [DOI] [PubMed] [Google Scholar]
  28. Thomas G. H., Goldberg M. F., Miller C. S., Reynolds L. W. Neuraminidase deficiency in the original patient with the Goldberg syndrome. Clin Genet. 1979 Nov;16(5):323–330. doi: 10.1111/j.1399-0004.1979.tb01010.x. [DOI] [PubMed] [Google Scholar]
  29. Thomas G. H., Tipton R. E., Ch'ien L. T., Reynolds L. W., Miller C. S. Sialidase (alpha-n-acetyl neuraminidase) deficiency: the enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia. Clin Genet. 1978 Apr;13(4):369–379. doi: 10.1111/j.1399-0004.1978.tb01194.x. [DOI] [PubMed] [Google Scholar]
  30. Van Diggelen O. P., Schram A. W., Sinnott M. L., Smith P. J., Robinson D., Galjaard H. Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency. Biochem J. 1981 Oct 15;200(1):143–151. doi: 10.1042/bj2000143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Warner T. G., O'Brien J. S. Synthesis of 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis. Biochemistry. 1979 Jun 26;18(13):2783–2787. doi: 10.1021/bi00580a014. [DOI] [PubMed] [Google Scholar]
  32. Wenger D. A., Tarby T. J., Wharton C. Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies. Biochem Biophys Res Commun. 1978 May 30;82(2):589–595. doi: 10.1016/0006-291x(78)90915-4. [DOI] [PubMed] [Google Scholar]
  33. van Diggelen O. P., Hoogeveen A. T., Smith P. J., Reuser A. J., Galjaard H. Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency. Biochim Biophys Acta. 1982 Apr 21;703(1):69–76. doi: 10.1016/0167-4838(82)90012-7. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES